Treatment of Covid-19 in America has been fragmented and uncoordinated, says expert leading UK programme
The global effort to produce useful anti-Covid medicines is being hampered by the US because researchers are testing drugs in “an arbitrary, willy-nilly way”, the expert leading the UK’s programme has warned.
Britain’s Recovery Trial programme, which has involved 12,000 patients at several hundred British hospitals, has already pinpointed one promising new drug to tackle the disease and also highlighted two others – previously thought to be potential life-savers – as being useless.
Continue reading...from The Guardian https://ift.tt/2ZYWJqP
